Skip to main content
NVDA-1.92%AAPL+1.34%GOOGL+0.21%MSFT-0.63%AMZN-0.92%TSM-1.79%SPCX-1.90%META-2.29%AVGO-1.55%TSLA-2.02%LLY+3.71%BRK-B-0.11%SKHY-3.52%MU-1.40%AMD-3.52%WMT+1.61%JPM+0.56%V-0.85%XOM+0.72%ASMLa+2.03%JNJ+1.24%MA-0.32%INTC-2.55%ABBV+2.97%0700.HK-0.42%1398.HK-0.92%CSCO+0.69%CVX+1.05%COST+1.20%KO+0.70%ORCL-7.40%PG+1.05%LRCX-2.73%AMAT-2.05%AP2d+0.34%UNH+2.83%BAC-7.66%DELL-7.63%CAT-1.55%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.43%GE+0.76%PM+1.64%0939.HK-1.00%1288.HK-2.23%NFLX-0.52%HD-1.10%USDMXN+1.03%USDSEK+0.95%USDCHF+0.93%CADCHF+0.76%USDZAR+0.73%AUDCHF+0.70%EURUSD-0.66%USDPLN+0.64%USDDKK+0.63%EURHKD-0.62%CHFJPY-0.62%GBPCHF+0.57%NZDUSD-0.56%EURCNH-0.54%EURCAD-0.50%USDSGD+0.49%USDTHB+0.47%NZDMXN+0.43%NZDCAD-0.42%EURAUD-0.42%GBPTRY+0.41%AUDDKK+0.40%USDNOK+0.37%GBPUSD-0.37%AUDNZD+0.36%EURJPY-0.35%PLNJPY-0.34%NZDCHF+0.34%GBPHKD+0.32%EURSEK+0.32%CHFSEK+0.31%USDJPY+0.30%GBPMXN-0.28%USDTRY+0.28%NZDJPY-0.28%EURGBP-0.27%CHFNOK-0.27%EURCHF+0.26%EURNOK-0.26%AUDSGD+0.25%AUDUSD-0.23%GBPNZD+0.19%SGDJPY-0.19%GBPZAR+0.19%GBPCAD-0.18%USDCAD+0.18%USDILS+0.16%EURSGD-0.14%CHFSGD-0.14%GBPAUD-0.13%AUDNOK+0.12%CADJPY+0.11%EURZAR+0.11%NZDSGD-0.11%USDCNH+0.08%GBPJPY-0.08%NOKJPY-0.07%AUDJPY+0.07%EURNZD-0.05%GBPSGD-0.05%AUDCAD-0.04%USDCOP-0.04%EURCZK+0.04%EURPLN+0.01%USDHKD+0.01%EURDKK+0.01%XAGUSD-4.86%GAGUSD-4.85%XPTUSD-2.69%XNGUSD-2.62%COFFEE+2.33%XAUUSD-1.53%GAUUSD-1.52%COCOA+0.75%COTTON+0.56%S1-0.53%SUGAR-0.52%HG1-0.41%BTCUSD-1.39%ETHUSD+15.24%USDTUSD0.00%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.88%ZECUSDT-4.04%DOGEUSD+11.12%XMRUSDT+0.54%LINKUSD+11.09%XLMUSD-3.42%BCHUSDT-1.61%UNIUSD-4.58%LTCUSD+9.37%SUIUSD-3.12%HBARUSDT-3.32%TONUSD+24.80%TAOUSDT-3.21%AAVEUSD-2.62%DOTUSDT-2.86%ICPUSDT-3.47%ONDOUSDT-4.74%WLDUSDT-5.00%ARBUSDT-5.22%JUPUSDT-4.07%ATOMUSDT-4.68%INJUSDT-3.72%STXUSDT-2.17%FETUSDT-3.31%PYTHUSDT+5.88%TIAUSDT-5.18%SEIUSDT-3.09%IMXUSDT-5.36%OPUSDT-10.56%GRTUSDT-3.79%WIFUSDT-3.70%IOTAUSDT-5.32%AXSUSDT-4.62%POLUSDT-4.91%EOSUSDT+3.99%FARTCOINUSDT-5.10%DYDXUSDT-5.74%GALAUSDT-5.44%ORDIUSDT-4.32%RONINUSDT-7.27%NOTUSDT-5.58%NVDA-1.92%AAPL+1.34%GOOGL+0.21%MSFT-0.63%AMZN-0.92%TSM-1.79%SPCX-1.90%META-2.29%AVGO-1.55%TSLA-2.02%LLY+3.71%BRK-B-0.11%SKHY-3.52%MU-1.40%AMD-3.52%WMT+1.61%JPM+0.56%V-0.85%XOM+0.72%ASMLa+2.03%JNJ+1.24%MA-0.32%INTC-2.55%ABBV+2.97%0700.HK-0.42%1398.HK-0.92%CSCO+0.69%CVX+1.05%COST+1.20%KO+0.70%ORCL-7.40%PG+1.05%LRCX-2.73%AMAT-2.05%AP2d+0.34%UNH+2.83%BAC-7.66%DELL-7.63%CAT-1.55%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.43%GE+0.76%PM+1.64%0939.HK-1.00%1288.HK-2.23%NFLX-0.52%HD-1.10%USDMXN+1.03%USDSEK+0.95%USDCHF+0.93%CADCHF+0.76%USDZAR+0.73%AUDCHF+0.70%EURUSD-0.66%USDPLN+0.64%USDDKK+0.63%EURHKD-0.62%CHFJPY-0.62%GBPCHF+0.57%NZDUSD-0.56%EURCNH-0.54%EURCAD-0.50%USDSGD+0.49%USDTHB+0.47%NZDMXN+0.43%NZDCAD-0.42%EURAUD-0.42%GBPTRY+0.41%AUDDKK+0.40%USDNOK+0.37%GBPUSD-0.37%AUDNZD+0.36%EURJPY-0.35%PLNJPY-0.34%NZDCHF+0.34%GBPHKD+0.32%EURSEK+0.32%CHFSEK+0.31%USDJPY+0.30%GBPMXN-0.28%USDTRY+0.28%NZDJPY-0.28%EURGBP-0.27%CHFNOK-0.27%EURCHF+0.26%EURNOK-0.26%AUDSGD+0.25%AUDUSD-0.23%GBPNZD+0.19%SGDJPY-0.19%GBPZAR+0.19%GBPCAD-0.18%USDCAD+0.18%USDILS+0.16%EURSGD-0.14%CHFSGD-0.14%GBPAUD-0.13%AUDNOK+0.12%CADJPY+0.11%EURZAR+0.11%NZDSGD-0.11%USDCNH+0.08%GBPJPY-0.08%NOKJPY-0.07%AUDJPY+0.07%EURNZD-0.05%GBPSGD-0.05%AUDCAD-0.04%USDCOP-0.04%EURCZK+0.04%EURPLN+0.01%USDHKD+0.01%EURDKK+0.01%XAGUSD-4.86%GAGUSD-4.85%XPTUSD-2.69%XNGUSD-2.62%COFFEE+2.33%XAUUSD-1.53%GAUUSD-1.52%COCOA+0.75%COTTON+0.56%S1-0.53%SUGAR-0.52%HG1-0.41%BTCUSD-1.39%ETHUSD+15.24%USDTUSD0.00%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.88%ZECUSDT-4.04%DOGEUSD+11.12%XMRUSDT+0.54%LINKUSD+11.09%XLMUSD-3.42%BCHUSDT-1.61%UNIUSD-4.58%LTCUSD+9.37%SUIUSD-3.12%HBARUSDT-3.32%TONUSD+24.80%TAOUSDT-3.21%AAVEUSD-2.62%DOTUSDT-2.86%ICPUSDT-3.47%ONDOUSDT-4.74%WLDUSDT-5.00%ARBUSDT-5.22%JUPUSDT-4.07%ATOMUSDT-4.68%INJUSDT-3.72%STXUSDT-2.17%FETUSDT-3.31%PYTHUSDT+5.88%TIAUSDT-5.18%SEIUSDT-3.09%IMXUSDT-5.36%OPUSDT-10.56%GRTUSDT-3.79%WIFUSDT-3.70%IOTAUSDT-5.32%AXSUSDT-4.62%POLUSDT-4.91%EOSUSDT+3.99%FARTCOINUSDT-5.10%DYDXUSDT-5.74%GALAUSDT-5.44%ORDIUSDT-4.32%RONINUSDT-7.27%NOTUSDT-5.58%
ML

Mesa Laboratories, Inc. (MLAB)

NASDAQ • Healthcare

$127.56
-$0.5 (-0.4%)
Market open

Last close at October 13, 2026 at 20:00 UTC

Open$127.76
Previous Close$127.56
Day Range$126.8 - $129.69
Avg. Volume (3M)119.4K
Market Cap$718.7M
P/E Ratio148.3
52 Week Range
$69.43$144.35
Next EarningsIn 22 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$60.1M100%
Gross Profitminus cost of goods$39M65%
Operating Incomeminus R&D and overhead$7M12%
Net Incomeminus taxes and the rest$2.8M5%

In plain terms: out of every $100 in revenue, Mesa Laboratories, Inc. keeps $5 as net profit.

Fundamentals & Financials

Revenue (TTM)
$249.7M
Net Income (TTM)
$4.8M
EPS (TTM)
$0.86
ROA (TTM)
1.14%
Current Ratio
2.07
Dividend Yield
0.16%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+119.3%Q1 2026$3.07
+32.1%Q2 2026$2.76
+1.9%Q3 2026$2.68
Next

Nov 5

in 22 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +1.9%

Mesa Laboratories’ adjusted EPS topped consensus even as revenue trailed expectations in the first fiscal quarter of 2027 (period ended June 30, 2026, reported August 10, 2026). Revenue rose 1.0% to about $60.1 million (up from roughly $59.5 million a year ago) and came in at $60.1 million versus the $60.9 million estimate (-1.2%, trailed). Profitability was supported by a gross margin of ~65% and an operating margin of ~12%, with gross profit of roughly $39.0 million and operating income of about $7.0 million. On the bottom line, net income fell 40.3% to around $2.8 million (down from about $4.7 million a year ago). Adjusted EPS of $2.68 topped the $2.63 estimate (+1.9%, topped). The company generated operating cash flow of about $14.7 million during the quarter and paid roughly $0.9 million in dividends. Next-period consensus calls for EPS of $1.59 on revenue of $61.6 million.

Next report — what to expect

Mesa Laboratories, Inc. (MLAB) reports on November 5, 2026. For the upcoming quarter, consensus calls for EPS of $2.29 on revenue of $62.2 million. As trailing context, revenue grew +1.0% year over year last quarter. Mesa has beaten EPS in 4 of 8 most recent quarters.

View full earnings history

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. (NASDAQ: MLAB) develops and sells medical and laboratory quality-control, diagnostics, and biopharma tools within healthcare, generating $249.1 million of revenue in FY2026. Its business spans sterilization and disinfection controls, clinical genomics, biopharmaceutical development, and calibration products used by regulated care and research customers.

Name
Mesa Laboratories, Inc.
CEO
Siddhartha C. Kadia
Website
www.mesalabs.com
Industry
Healthcare
Year Founded
1982
Employees
717

Today's Snapshot

AI-generated

MLAB closed slightly lower at 127.56.

Trading Volume

Below 10d avg (108.1K)

107.5K

vs S&P 500 Today

Moderate Underperformance

-0.38%

Updated: October 14, 2026 at 12:18 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
MLAB displays a bullish longer‑term profile with the price comfortably above the 50‑, 100‑ and 200‑day averages while short‑term moving averages sit higher, indicating a recent pullback. Momentum breadth is constructive with a positive MACD and buy signals from slower oscillators, and ADX above 30 signals a well‑defined trend. ATR indicates moderate volatility and on‑balance volume is mixed, giving only partial confirmation of price action. The pivot is essentially at the current level and not decisive. Technical takeaway: Buy — longer‑term trend and momentum are supportive despite short‑term consolidation.
All signals
  • EMA (5 indicators)$103.34 - $129.91
    Buy
  • RSI (14)48.85
    Neutral
  • Stochastic %K (14, 3, 3)13.44
    Buy
  • MACD Level (12, 26)1.46
    Neutral

Peers & Related Assets

TMOThermo Fisher Scientific Inc.
$676.3+2.0%
AAgilent Technologies, Inc.
$171.6+0.2%
RVTYRevvity, Inc.
$155.08-0.3%
TECHBio-Techne Corporation
$72.48-0.1%
BIOBio-Rad Laboratories, Inc.
$363.73-0.2%
QGENQiagen N.V.
$45.44+0.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.